ArticleCase reports in endocrinology2025

New-Onset Autoantibody-Negative Diabetes With DKA Following Lorlatinib Therapy for ALK-Positive NSCLC.

Ashni Dharia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.